Topic
alzheimers-disease
15 stories related to this topic, newest first.
rediff.comworld4 hrs ago
Dementia Projected to Cost U.S. $818 Billion in 2026
A USC-led study estimates total economic costs from Alzheimer's disease and related dementias will reach $818 billion this year. The figure includes medical spending, unpaid caregiving, lost earnings, and reduced quality of life.
neurosciencenews.comscience28 days ago
Blood Test Predicts Alzheimer's Disease in Large Cohort
A blood test measuring p-tau217 levels showed strong performance in identifying Alzheimer's disease among participants with an average age of 61. The findings appear in a new issue of a medical journal.
ER
New York Postscience32 days ago
Study Links Memory Concerns and pTau181 Protein to Alzheimer’s at Age 45
Researchers analyzing data from more than 1,000 people around age 45 found that self-reported memory problems combined with elevated pTau181 protein levels may indicate Alzheimer’s risk up to two decades before typical diagnosis.
Fox Newspolitics35 days ago
Alzheimer's Blood Tests Face Medicare Coverage Limits
Medicare covers tau protein blood tests only after symptoms appear. New legislation would expand coverage for earlier detection.
news.google.comscience36 days ago
Essay Examines Immune System Role in Preventing Alzheimer's Disease
A recent essay discusses connections between the immune system and brain health. It explores how these interactions might help prevent neurodegenerative conditions such as Alzheimer's disease.
ER
MarketWatchfinance37 days ago
Alzheimer’s Lifetime Care Costs Exceed $400,000
The lifetime cost of care for someone with Alzheimer’s disease now tops $400,000. Experts note the figure will grow as the population ages.
MA
Statscience42 days ago
Biogen Advances Tau-Targeting Alzheimer’s Drug to Phase 3 Despite Mixed Phase 2 Data
Biogen reported that its drug diranersen reduced tau levels in spinal fluid and brains of patients with early-stage Alzheimer’s in a Phase 2 trial. The reductions correlated with slower cognitive decline, though the study did not meet its primary efficacy goal of showing a dose r…
ncbi.nlm.nih.govscience43 days ago
Blood Test May Predict Dementia Risk Before Symptoms Appear
Researchers analyzed blood metabolites from more than 220,000 UK residents and found that individuals whose biological age exceeded their chronological age faced higher dementia risk. The link was stronger for vascular dementia. The study suggests biological aging data could iden…
Euronewsworld44 days ago
Roche's pTau217 Blood Test Receives CE Mark for Use in Europe
Roche announced Tuesday that its Elecsys pTau217 test, the first blood test designed to signal and rule out Alzheimer’s disease, has been cleared for use across the European Union. Developed with Eli Lilly and Company, the test aims to speed diagnosis for millions facing lengthy…
Statscience45 days ago
Medicare Spending on New Alzheimer’s Drugs Falls Below Projections
Medicare payments for recently approved Alzheimer’s medications are coming in well below earlier forecasts. A spokesperson for the Centers for Medicare and Medicaid Services said uptake of the drugs has been muted and the agency is not projecting significant spending in 2026 or 2…
Nbc Newsscience45 days ago
Neurologist Shares Ways to Maintain Brain Health
A neurologist appeared on a morning program to explain the difference between brain fog and cognitive decline. The doctor outlined simple daily steps that can support brain function over time. The segment addressed common questions about brain health and aging.
foxnews.comscience45 days ago
Medicare Spending on Newly Approved Alzheimer’s Drugs Leqembi and Kisunla Far Below Initial Projections
Uptake of the recently approved intravenous Alzheimer’s medications has been far lower than anticipated, prompting Medicare to forecast no significant spending on Leqembi and Kisunla in 2026 or 2027. Two years ago the program projected billions of dollars annually on Leqembi alon…
Statscience45 days ago
Medicare Spending on Alzheimer’s Drugs Leqembi and Kisunla Far Below Initial Projections
Uptake of the recently approved intravenous medications has been far lower than anticipated, prompting the Centers for Medicare and Medicaid Services to project no significant spending in 2026 or 2027. The muted adoption marks a sharp reversal from projections made two years ago.
Fox Newsscience48 days ago
Moderate Egg Consumption Linked to Lower Alzheimer's Risk in Observational Study of Older Adults
Researchers at Loma Linda University found that adults over 65 who ate eggs one to three times per month or once per week had a 17% lower risk of Alzheimer's disease, while those consuming eggs five or more times per week showed a 27% lower risk. The observational study, publishe…
reason.comworld50 days ago
Alzheimer’s Research Scandal Highlights Problems in Scientific Oversight
A major Alzheimer’s disease research finding that influenced billions of dollars in federal funding was later found to contain manipulated images. The case has drawn attention to broader issues of research integrity, incentives in academic publishing, and oversight of taxpayer-fu…